Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss availability, eligibility and decisions regarding clinical trials and the differences in treatment options. This is part six of a nine part series. Dr. Growden explains that carcinosarcomas are generally excluded from clinical trials, although uterine carcinosarcoma has been allowed in some trials. … Continue reading How to Find a Clinical Trial with Dr. Whitfield Growden (Part 6) [VIDEO]
Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss genomic analysis, patterns of resistance, and immunotherapy. This is part five of a nine part series. Dr. Growden discusses tumor specimens used for genomic analysis and the impact of tumor changes. Recognizing patterns of resistance is very important for treatment. Also discussed … Continue reading Genome Analysis and Immunotherapy with Dr. Whitfield Growden (Part 5) [VIDEO]
Patient/advocate Diane Redington and Dr. Whitfield Growden discuss the management of ovarian and uterine carcinosarcoma. This is part four of a nine part series. Dr. Growden discusses important differences between ovarian and uterine carcinosarcoma and takes us through the stages of ovarian and uterine carcinosarcoma cancers and treatment modalities for … Continue reading Diagnosis and Treatment of Gyn Carcinosarcoma (MMMT) with Dr. Whitfield Growden (Part 4) [VIDEO]
Patient/advocate Diane Redington and Dr. Whitfield Growden discuss current scientific findings and clinical trials in ovarian and uterine carcinosarcoma. This is part three of a nine part series. Dr. Growden discusses how they have examined tumors (from Mass General’s tumor bank) of the fallopian tubes, ovary, uterus, and vagina. They … Continue reading Research and Clinical Trials with Dr. Whitfield Growden (Part 3) [VIDEO]
The second of two interviews conducted on January 5, 2017, with Diane Redington and Dr. Growdon on the topic of carcinosarcoma. This interview discusses: genomic analysis of carcinosarcoma, patterns of resistance, immunotherapy and clinical trials.
The following transcript is from an interview between Dr. Whitfield Growdon (MDC), a leading GYN Oncological Surgeon from Mass General Cancer Center in Boston and Diane Redington (DR), a woman with a Gynecological Carcinosarcoma (GCS) who is seeking to motivate researchers to advance the science and uncover knowledge about carcinosarcoma and find a cure for this cancer. This interview discusses diagnosis and treatment of MMMT.